Amrutanjan Health Care
Amrutanjan Health Care Performance
Day Range
- Low 613.15
- High 624.85
52 Week Range
- Low 554.05
- High 775.45
- Open Price614.6
- Previous Close614.6
- Volume37601
Start SIP in Amrutanjan Health Care
Start SIPAmrutanjan Health Care Investment Rating
-
Master Rating:
-
Amrutanjan Health Care has an operating revenue of Rs. 386.54 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of 14% is healthy, ROE of 13% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 91 which is a GREAT score indicating consistency in earnings, a RS Rating of 11 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 92 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 78 | 100 | 98 | 111 | 71 | 107 |
Operating Expenses Qtr Cr | 71 | 87 | 85 | 95 | 68 | 90 |
Operating Profit Qtr Cr | 7 | 13 | 12 | 16 | 3 | 16 |
Depreciation Qtr Cr | 1 | 1 | 1 | 2 | 1 | 1 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 2 | 4 | 4 | 5 | 2 | 5 |
Net Profit Qtr Cr | 7 | 13 | 11 | 13 | 4 | 15 |
Amrutanjan Health Care Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹628.87
- 50 Day
- ₹633.41
- 100 Day
- ₹637.85
- 200 Day
- ₹655.77
- 20 Day
- ₹632.3
- 50 Day
- ₹632.77
- 100 Day
- ₹635.31
- 200 Day
- ₹646.75
Amrutanjan Health Care Resistance and Support
Resistance | |
---|---|
First Resistance | ₹622.96 |
Second Resistance | ₹629.75 |
Third Resistance | ₹634.65 |
RSI | 40.93 |
MFI | 32.62 |
MACD Single Line | -0.78 |
MACD | -2.54 |
Support | |
---|---|
First Resistance | ₹611.25 |
Second Resistance | ₹606.35 |
Third Resistance | ₹599.55 |
Amrutanjan Health Care Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 40,842 | 1,387,811 | 33.98 |
Week | 29,089 | 1,078,344 | 37.07 |
1 Month | 45,425 | 2,290,312 | 50.42 |
6 Month | 74,402 | 2,605,565 | 35.02 |
Amrutanjan Health Care Result Highlights
Amrutanjan Health Care Synopsis
NSE-Medical-Generic Drugs
Amrutanjan Health Ca is involved in the business activities of Manufacture of `ayurvedic’ or `unani’ pharmaceutical preparation. Company’s Total Operating Revenue is Rs. 379.64 Cr. and Equity Capital is Rs. 2.92 Cr. for the Year ended 31/03/2023. Amrutanjan Health Care Ltd. is a Public Limited Listed company incorporated on 09/09/1936 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24231TN1936PLC000017 and registration number is 000017.Market Cap | 1,801 |
Sales | 387 |
Shares in Float | 1.46 |
No of funds | 28 |
Yield | 0.75 |
Book Value | 6.19 |
U/D Vol ratio | 0.6 |
LTDebt / Equity | |
Alpha | -0.03 |
Beta | 0.38 |
Amrutanjan Health Care
Owner Name | Jun-23 | Mar-23 | Dec-22 | Sep-22 |
---|---|---|---|---|
Promoters | 50.04% | 50.04% | 50.02% | 50.02% |
Mutual Funds | 6.93% | 6.92% | 6.14% | 6.06% |
Foreign Portfolio Investors | 0.69% | 0.68% | 0.76% | 0.87% |
Financial Institutions/ Banks | 0.09% | 0.09% | 0.09% | 0.09% |
Individual Investors | 35.03% | 35.38% | 35.99% | 36.09% |
Others | 7.22% | 6.89% | 7% | 6.87% |
Amrutanjan Health Care Management
Name | Designation |
---|---|
Mr. S Sambhu Prasad | Chairman & Managing Director |
Dr. Pasumarthi S N Murthi | Non Executive Director |
Mr. G Raghavan | Ind. Non-Executive Director |
Dr.(Ms.) Marie Shiranee Pereira | Ind. Non-Executive Director |
Dr. S Vydeeswaran | Ind. Non-Executive Director |
Mr. Raja Venkataraman | Ind. Non-Executive Director |
Mr. S Muralidharan | Ind. Non-Executive Director |
Amrutanjan Health Care Forecast
Price Estimates
Amrutanjan Health Care Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-08-02 | Quarterly Results | |
2023-06-30 | Buy Back of Shares | |
2023-05-30 | Audited Results & Final Dividend | (Revised) per share(55%)First Interi |
2023-02-14 | Quarterly Results & Interim Dividend | |
2022-11-04 | Quarterly Results & Interim Dividend |
Date | Purpose | Remarks |
---|---|---|
2023-09-14 | FINAL | Rs.2.60 per share(260%)Final Dividend |
2023-02-24 | INTERIM | Rs.1.00 per share (100%) Second Interim Dividend |
2022-11-15 | INTERIM | Rs.1.00 per share(100%)First Interim Dividend |
2022-02-21 | INTERIM | Rs.1.00 per share(100%)Second Interim Dividend |
2021-11-17 | INTERIM | Re.1.00 per share (100%) First Interim Dividend |
- Company Name
- CMP
- Chg(%)
- Hindalco Inds.
- 493
- 5.5
- NTPC
- 246
- 3.6
- Hero Motocorp
- 3057
- 2.9
- Dr Reddys Labs
- 5587
- 2.9
- Divis Lab.
- 3765
- 2.7
- Company Name
- CMP
- Chg(%)
- Adani Enterp.
- 2414
- -2.5
- LTIMindtree
- 5210
- -1.0
- HCL Technologies
- 1235
- -0.6
- Tech Mahindra
- 1223
- -0.5
- Power Grid Corpn
- 200
- -0.5
Amrutanjan Health Care FAQs
What is Share Price of Amrutanjan Health Care ?
Amrutanjan Health Care share price is ₹616 As on 30 September, 2023 | 17:21
What is the Market Cap of Amrutanjan Health Care ?
The Market Cap of Amrutanjan Health Care is ₹1801 Cr As on 30 September, 2023 | 17:21
What is the P/E ratio of Amrutanjan Health Care ?
The P/E ratio of Amrutanjan Health Care is 41.7 As on 30 September, 2023 | 17:21
What is the PB ratio of Amrutanjan Health Care ?
The PB ratio of Amrutanjan Health Care is 6.2 As on 30 September, 2023 | 17:21